Lipocalin-type prostaglandin d2 synthase production promoting agent
AssigneesHyogo College of Medicine, Nippon Zoki Pharmaceutical Co., Ltd.
InventorsTomohiro MATSUYAMA, Takayuki NAKAGOMI, Yu FUKUDA
Life of this patent
Estimating the term…
Loading patent…
AssigneesHyogo College of Medicine, Nippon Zoki Pharmaceutical Co., Ltd.
InventorsTomohiro MATSUYAMA, Takayuki NAKAGOMI, Yu FUKUDA
Estimating the term…
A lipocalin-type prostaglandin D2 synthase (L-PGDS) production promoting agent, more specifically an L-PGDS production promoting agent in pericytes or ischemia-induced multipotent stem cells (iSCs) dedifferentiated from pericytes. A substance having an L-PGDS production promoting action is contained in an extract from inflamed tissues inoculated with vaccinia virus. An L-PGDS production promoting agent is highly useful as a prophylactic, therapeutic or relapse prophylactic agent for a disease in which the effect by promotion of L-PGDS expression is expected to be effective, including a cerebrovascular disorder such as cerebral infarction, dementia such as Alzheimer's disease, or a sleep disorder.
A method for promoting production of a lipocalin-type prostaglandin D2 synthase in a patient in need thereof, the method comprising:
(canceled)
A screening method for a substance having a brain-protective action or a sleep-promoting action, the method comprising:
(canceled)
(canceled)
A determining or evaluating method for an extract from inflamed tissues inoculated with vaccinia virus or a preparation containing the extract, comprising determining a lipocalin-type prostaglandin D2 synthase expression-promoting action of the extract or the preparation containing the extract.
(canceled)
Dependencies are inferred from the claim text.